Skip to main content
Top
Published in: Internal and Emergency Medicine 7/2021

01-10-2021 | Aspiration Pneumonia | IM - ORIGINAL

Association of early antibiotic therapy and in-hospital mortality in adult mild-to-moderate acute aspiration pneumonitis: a cohort study

Authors: Masaharu Aga, Toru Naganuma, Yusuke Ohashi, Hiroki Matsuzawa, Suguru Matsuzaka, Ivor Cammack, Gen Yamada, Yoshimoto Serizawa

Published in: Internal and Emergency Medicine | Issue 7/2021

Login to get access

Abstract

Background

Patients with aspiration pneumonitis often receive empiric antibiotic therapy despite it being due to a non-infectious, inflammatory response.

Objective

To study the benefits of early antibiotic therapy in patients with suspected aspiration pneumonitis in an acute care hospital.

Design

Retrospective cohort study using electronic medical records from Teine Keijinkai Hospital.

Participants

Adults aged over 18 years admitted with a diagnosis of aspiration pneumonitis to the Department of General Internal Medicine or Emergency Department between January 1, 2008, and May 31, 2019. A diagnosis of aspiration pneumonitis was defined as a documented macro-aspiration event and a chest radiograph demonstrating new radiographic infiltrates.

Main measures

Patients were classified into the “early antibiotic treatment” group and the “no or late treatment” group depending on whether they received antibiotic therapy for respiratory bacterial pathogens within 8 h of arrival. The primary outcome was in-hospital all-cause mortality. Secondary outcomes included length of hospital stay, antibiotic-free days, duration of fever, readmission within one month, and incidence of complications.

Key results

Of the 146 patients enrolled, 52 (35.6%) did not receive early antibiotic therapy, while the remaining 94 (64.4%) did. There was no difference in in-hospital mortality rates between the groups after adjustment for potential confounding variables using Cox proportional hazards analysis (hazard ratio 2.78; 95% confidence interval, 0.57–13.50, p = 0.20). Patients in the no or late treatment group had more antibiotic-free days (p < 0.001) and a shorter length of hospital stay among survivors (p = 0.040) than did those in the early antibiotic treatment group. There were no statistically significant differences between the groups with respect to other secondary outcomes.

Conclusions

Early antibiotic therapy for acute aspiration pneumonitis was not associated with in-hospital mortality, but was associated with a longer hospital stay and prolonged use of antibiotics.
Appendix
Available only for authorised users
Literature
1.
go back to reference DiBardino DM, Wunderink RG (2015) Aspiration pneumonia: a review of modern trends. J Crit Care 30:40–48CrossRef DiBardino DM, Wunderink RG (2015) Aspiration pneumonia: a review of modern trends. J Crit Care 30:40–48CrossRef
2.
go back to reference Mendelson CL (1946) The aspiration of stomach contents into the lungs during obstetric anesthesia. Am J Obstet Gynecol 52:191–205CrossRef Mendelson CL (1946) The aspiration of stomach contents into the lungs during obstetric anesthesia. Am J Obstet Gynecol 52:191–205CrossRef
3.
go back to reference Mandell LA, Niederman MS (2019) Aspiration pneumonia. N Engl J Med 380:651–663CrossRef Mandell LA, Niederman MS (2019) Aspiration pneumonia. N Engl J Med 380:651–663CrossRef
4.
go back to reference Raghavendran K, Nemzek J, Napolitano LM, Knight PR (2011) Aspiration induced lung injury. Crit Care Med 39:818–826CrossRef Raghavendran K, Nemzek J, Napolitano LM, Knight PR (2011) Aspiration induced lung injury. Crit Care Med 39:818–826CrossRef
5.
go back to reference Rebuck JA, Rasmussen JR, Olsen KM (2001) Clinical aspiration-related practice patterns in the intensive care unit: a physician survey. Crit Care Med 29:2239–2244CrossRef Rebuck JA, Rasmussen JR, Olsen KM (2001) Clinical aspiration-related practice patterns in the intensive care unit: a physician survey. Crit Care Med 29:2239–2244CrossRef
6.
go back to reference Kane-Gill SL, Olsen KM, Rebuck JA, Rea RS, Boatwright DW, Smythe MA (2007) Multicenter treatment and outcome evaluation of aspiration syndromes in critically ill patients. Ann Pharmacother 41:549–555CrossRef Kane-Gill SL, Olsen KM, Rebuck JA, Rea RS, Boatwright DW, Smythe MA (2007) Multicenter treatment and outcome evaluation of aspiration syndromes in critically ill patients. Ann Pharmacother 41:549–555CrossRef
7.
go back to reference Magill SS, Edwards JR, Beldavs ZG et al (2014) Prevalence of antimicrobial use in US acute care hospitals, May–September 2011. JAMA 312:1438–1446CrossRef Magill SS, Edwards JR, Beldavs ZG et al (2014) Prevalence of antimicrobial use in US acute care hospitals, May–September 2011. JAMA 312:1438–1446CrossRef
8.
go back to reference Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ (2003) Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 163:972–978CrossRef Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ (2003) Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 163:972–978CrossRef
9.
go back to reference Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE (2017) Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 177:1308–1315CrossRef Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE (2017) Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 177:1308–1315CrossRef
10.
go back to reference Dragan V, Wei Y, Elligsen M, Kiss A, Walker SAN, Leis JA (2018) Prophylactic antimicrobial therapy for acute aspiration pneumonitis. Clin Infect Dis 67:513–518CrossRef Dragan V, Wei Y, Elligsen M, Kiss A, Walker SAN, Leis JA (2018) Prophylactic antimicrobial therapy for acute aspiration pneumonitis. Clin Infect Dis 67:513–518CrossRef
11.
go back to reference Lee JS, Giesler DL, Gellad WF, Fine MJ (2016) Antibiotic therapy for adults hospitalized with community-acquired pneumonia: a systematic review. JAMA 315:593–602CrossRef Lee JS, Giesler DL, Gellad WF, Fine MJ (2016) Antibiotic therapy for adults hospitalized with community-acquired pneumonia: a systematic review. JAMA 315:593–602CrossRef
12.
go back to reference Waterer GW, Self WH, Courtney DM et al (2018) In-hospital deaths among adults with community-acquired pneumonia. Chest 154:628–635CrossRef Waterer GW, Self WH, Courtney DM et al (2018) In-hospital deaths among adults with community-acquired pneumonia. Chest 154:628–635CrossRef
13.
go back to reference Renaud B, Labarère J, Coma E et al (2009) Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule. Crit Care 13:R54CrossRef Renaud B, Labarère J, Coma E et al (2009) Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule. Crit Care 13:R54CrossRef
14.
go back to reference Fine MJ, Auble TE, Yealy DM et al (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250CrossRef Fine MJ, Auble TE, Yealy DM et al (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250CrossRef
15.
go back to reference Son YG, Shin J, Ryu HG (2017) Pneumonitis and pneumonia after aspiration. J Dent Anesth Pain Med 17:1–12CrossRef Son YG, Shin J, Ryu HG (2017) Pneumonitis and pneumonia after aspiration. J Dent Anesth Pain Med 17:1–12CrossRef
16.
go back to reference Lim WS, van der Eerden MM, Laing R et al (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377–382CrossRef Lim WS, van der Eerden MM, Laing R et al (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377–382CrossRef
17.
go back to reference Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458CrossRef Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458CrossRef
18.
go back to reference Cameron JL, Mitchell WH, Zuidema GD (1973) Aspiration pneumonia. Clinical outcome following documented aspiration. Arch Surg. 106:49–52CrossRef Cameron JL, Mitchell WH, Zuidema GD (1973) Aspiration pneumonia. Clinical outcome following documented aspiration. Arch Surg. 106:49–52CrossRef
19.
go back to reference Bynum LJ, Pierce AK (1976) Pulmonary aspiration of gastric contents. Am Rev Respir Dis 114:1129–1136PubMed Bynum LJ, Pierce AK (1976) Pulmonary aspiration of gastric contents. Am Rev Respir Dis 114:1129–1136PubMed
Metadata
Title
Association of early antibiotic therapy and in-hospital mortality in adult mild-to-moderate acute aspiration pneumonitis: a cohort study
Authors
Masaharu Aga
Toru Naganuma
Yusuke Ohashi
Hiroki Matsuzawa
Suguru Matsuzaka
Ivor Cammack
Gen Yamada
Yoshimoto Serizawa
Publication date
01-10-2021
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 7/2021
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-021-02695-y

Other articles of this Issue 7/2021

Internal and Emergency Medicine 7/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine